deaths, originate from the lung, liver, stomach, colorectum, breast,
esophagus, pancreas, and prostate (2014 World Cancer Report), all
of which requiring EMT/METs in their developmental ontogeny
and being derived (except for the mammary gland) from the endoderm germ layer [1], suggesting that human cancer incidence/
mortality preferentially affects endoderm-derived epithelial structures. It is therefore not surprising that both developmental and
cancer biologists have become increasingly interested in applying
the EMT/MET concept in their respective research and in trying to
uncover common regulators for both physiological (developmental) and pathological (disease) EMT/METs [2, 3].
A common theme emerged from such studies in recent years
concerns the issue of EMT/MET diversity as it has become increasingly clear that in both development and cancer, a complete transition of E to M or M to E is rare [4]. Most EMT/MET phenomena
involve transitions that partially overlap with the full spectrum
between full epithelium and full mesenchyme (Fig. 2). With such
observations came questions of whether diverse EMT/METs could
have a standardized definition with a conserved set of regulators
and, if not, whether comparison between developmental and cancer
EMT/METs (or between any two EMT/METs) is meaningful [5].
Answer to these questions will come from advancement in
related fields of cellular, molecular, biophysical, bioinformatic,
and computational research that will place precise quantitative
values to each EMT/MET descriptor [6, 7]. For example, both
epithelial and mesenchymal cells are polarized, and their polarity is
Fig. 1 Number of EMT-related publications by year, from 1980 to June 2019, based on Web of Science search
30
Sofiane Hamidi et al.
Précédent

- 43/425

Suivant